These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12973692)

  • 1. Alpha-synuclein: between synaptic function and dysfunction.
    Di Rosa G; Puzzo D; Sant'Angelo A; Trinchese F; Arancio O
    Histol Histopathol; 2003 Oct; 18(4):1257-66. PubMed ID: 12973692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synucleins in synaptic plasticity and neurodegenerative disorders.
    Clayton DF; George JM
    J Neurosci Res; 1999 Oct; 58(1):120-9. PubMed ID: 10491577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of alpha-, beta-, and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases.
    Duda JE; Shah U; Arnold SE; Lee VM; Trojanowski JQ
    Exp Neurol; 1999 Dec; 160(2):515-22. PubMed ID: 10619569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synucleins--to have or not to have].
    Ninkina NN; Bukhman VL
    Genetika; 2000 Nov; 36(11):1487-91. PubMed ID: 11094765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein and neurodegenerative diseases.
    Goedert M
    Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.
    Chandra S; Fornai F; Kwon HB; Yazdani U; Atasoy D; Liu X; Hammer RE; Battaglia G; German DC; Castillo PE; Südhof TC
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14966-71. PubMed ID: 15465911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses.
    Trojanowski JQ; Lee VM
    Neurotoxicology; 2002 Oct; 23(4-5):457-60. PubMed ID: 12428717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synuclein family.
    Lavedan C
    Genome Res; 1998 Sep; 8(9):871-80. PubMed ID: 9750188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-synuclein: normal function and role in neurodegenerative diseases.
    Norris EH; Giasson BI; Lee VM
    Curr Top Dev Biol; 2004; 60():17-54. PubMed ID: 15094295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders.
    Uversky VN
    J Biomol Struct Dyn; 2003 Oct; 21(2):211-34. PubMed ID: 12956606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of alpha-synuclein and its significance].
    Nonaka T; Iwatsubo T; Hasegawa M
    Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein oligomerization: a role for lipids?
    Welch K; Yuan J
    Trends Neurosci; 2003 Oct; 26(10):517-9. PubMed ID: 14522142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.
    Gispert S; Del Turco D; Garrett L; Chen A; Bernard DJ; Hamm-Clement J; Korf HW; Deller T; Braak H; Auburger G; Nussbaum RL
    Mol Cell Neurosci; 2003 Oct; 24(2):419-29. PubMed ID: 14572463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases.
    Goedert M
    Curr Opin Genet Dev; 2001 Jun; 11(3):343-51. PubMed ID: 11377973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
    Krüger R; Müller T; Riess O
    J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkin and alpha-synuclein: opponent actions in the pathogenesis of Parkinson's disease.
    Baptista MJ; Cookson MR; Miller DW
    Neuroscientist; 2004 Feb; 10(1):63-72. PubMed ID: 14987449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.